Korneuburg, Septmeber 16, 2025 - Marinomed Biotech AG (the "Company") announces that the Management Board has resolved today to increase the Company's share capital by EUR 61.607 to EUR 1.839.940 by issuing 61.607 new no-par value bearer shares against cash contributions. The new shares will be issued from the authorized capital 2024/II and are subject to the direct exclusion of the statutory subscription rights of existing shareholders. The issue price per new share is EUR 17,50 so that the total issue price amounts to EUR 1,078,123. The Company's Supervisory Board approved this capital increase today, immediately after the Management Board passed the resolution. All 61.607 new shares have been subscribed at these issue terms and conditions by a total of nine investors.
+++ End of ad-hoc announcement +++